- Home
- VFC vs RLAY Comparison
VFC vs RLAY Comparison
Compare VFC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VFC | RLAY |
|---|---|---|
| Founded | 1899 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.1B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VFC | RLAY |
|---|---|---|
| Price | $13.96 | $17.89 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 18 | 10 |
| Target Price | $18.24 | ★ $19.50 |
| AVG Volume (30 Days) | ★ 6.2M | 3.0M |
| Earning Date | 05-20-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 233.33 | 31.78 |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $10,488,556,000.00 | $15,355,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.06 | $324.03 |
| P/E Ratio | $21.41 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $12.46 | $5.01 |
| 52 Week High | $22.27 | $21.27 |
Technical Indicators
Market Signals| Indicator | VFC | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 55.09 | 40.24 |
| Support Level | $12.46 | $11.68 |
| Resistance Level | $15.32 | $20.29 |
| Average True Range (ATR) | 0.39 | 0.84 |
| MACD | 0.20 | -0.12 |
| Stochastic Oscillator | 96.75 | 22.67 |
Price Performance
Historical ComparisonAbout VFC V.F. Corporation
VF designs, produces, and distributes apparel, footwear, and accessories with a focus on active and outdoor brands. Its portfolio of 10 labels includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and company-owned and partner-owned branded stores. Tracing its roots to 1899, VF has evolved into its present form through many brand acquisitions and divestitures.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.